Stay updated on Immunotherapy+Radiotherapy in Metastatic Genitourinary Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+Radiotherapy in Metastatic Genitourinary Cancers Clinical Trial page.

Latest updates to the Immunotherapy+Radiotherapy in Metastatic Genitourinary Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The current revision label is now displayed in the footer.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed. The change affects only the revision history entries.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedA new revision entry (v3.4.2) was added to the history and an outdated notice and the v3.4.1 entry were removed; this is routine record-keeping and does not affect core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check51 days agoChange DetectedThe additions are site-wide notices and a software revision (v3.4.1) replacing v3.4.0, which do not change study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check58 days agoChange DetectedShow glossary feature is now displayed, and the history uses color-coded highlights (green for additions, red for deletions) with the current revision listed as v3.4.0. The previous No FEAR Act data entry and the v3.3.4 revision note were removed from the history.SummaryDifference1%

- Check72 days agoChange DetectedRecord History now shows a new revision entry (v3.3.4) and removes the prior revision (v3.3.3).SummaryDifference0.1%

Stay in the know with updates to Immunotherapy+Radiotherapy in Metastatic Genitourinary Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+Radiotherapy in Metastatic Genitourinary Cancers Clinical Trial page.